During therapy with fluoroquinolones adverse CNS reactions such as dizzines
s, light-headedness, insomnia or sleepiness are observed in up to 20% of pa
tients. Using a device developed at our institute for the simultaneous regi
stration of the activity of rats housed in single cages, we have investigat
ed the effects of trovafloxacin, fleroxacin or ofloxacin on the locomotor a
ctivity of juvenile and adult rats (11 per group) after oral administration
of 600 mg:kg for 5 consecutive days. The effects were most pronounced afte
r fleroxacin, which induced a reduction in activity to 36 +/-9% (mean +/- S
D) of the values measured in juvenile rats before treatment and to 60 +/- 2
1% (mean +/- SD) in adult rats. HPLC analysis of the plasma concentrations
in juvenile rats showed that the concentrations of trovafloxacin were consi
derably lower than those of the other fluoroquinolones that had been studie
d previously in our laboratory: the peak concentration of trovafloxacin was
14 +/-2.9 mg/l (mean +/- SD) after a single dose of 600 mg/kg in juvenile
rats. Overall, we showed that the locomotor activities of juvenile and adul
t rats were significantly depressed during treatment with fluoroquinolones.
The effects were more pronounced in juveniles, Monitoring of the locomotor
activity of rats is a suitable approach to study CNS effects of fluoroquin
olones in animals, but pharmacokinetics have to be taken into account.